Controlled Substances and Inventory: Issues for Maryland’s Dispensing Physicians

Controlled Substances and Inventory: Issues for Maryland's Dispensing Physicians

This module was Board-approved and DHMH Secretary-approved to meet the CME requirements for dispensing permits.

The practice of dispensing any medication faces a certain amount of control and regulation, but when that medication is considered a “Controlled Substance” by the DEA, the control and regulation is taken to a whole new level. This module focuses on the intricacies of controlled substance laws and regulations as well as other practice nuances that will benefit any clinic considering dispensing these medications.

CE: 1.25 AMA PRA Category 1 Credit™; 1.25 ACPE Contact Hours
Universal Activity Number (UAN): 0025-0000-22-073-H03-P
Launch Date: 08/18/2022
Expiration Date: 08/18/2025
Course Number: CN#MD003
Target Audience: Physicians, Dentists
Course Details (Activity Announcement): View File (MD003 Activity Announcement)

Other modules in this series include:


ACPE LogoThe University of Maryland School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.


Learning Objectives (Physicians):
At the end of this application-based activity, the physician participant should be able to:

  1. Navigate online resources to find specific laws and regulations regarding controlled substances;
  2. Differentiate between the schedule classes of controlled substances as defined by the Controlled Substances Act (CSA) and match the dispensing, security, recordkeeping and DEA forms requirements for each; and
  3. Utilize best practices for inventory and maintaining records for inspection.


Joey Mattingly, PharmD, MBA, PhD
Assistant Professor, University of Maryland School of Pharmacy (at the time of recording)

Associate Professor and Vice-Chair of Research, Department Pharmacotherapy, University of Utah College of Pharmacy (current)  

Dr. Mattingly, instructor for this activity, has no financial relationships to disclose. None of the planners for this activity have financial relationships to disclose.

ACCME Information

Disclosure and Transparency in CME/CPD:
It is MedChi’s policy to ensure the independence, transparency, balance, objectivity, scientific rigor and integrity, as well as validation of content for all CME/CPD activities we accredit. To that end, faculty must disclose to the participants any relationships with companies identified as meeting the ACCME definition of a commercial interest. In the process of the disclosure process, all faculty and planners have disclosed the presences or absence of such relationships to MedChi. MedChi has identified, evaluated and where appropriate, attempted to resolve any potential conflicts of interest. This is done through the use of content validation, the use of evidence-based data, and multi-disciplinary peer review. The information provided as disclosure to the learner, is to inform the learner and aide in judgment, not to imply that disclosed relationships will have a negative effect on a presentation.

Planners: The planners for this activity have reported no relevant relationships to disclose.
Controlled Substances and Inventory: Issues for Maryland's Dispensing Physicians
Joey Mattingly, PharmD, has reported no relevant relationships to disclose.

Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedChi, The Maryland State Medical Society, and The University of Maryland School of Pharmacy. MedChi is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statements:
Controlled Substances and Inventory: Issues for Maryland's Dispensing Physicians
MedChi designates this live educational activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This module was Board-approved and DHMH Secretary-approved to meet the CME requirements for dispensing permits.

CME Credit: In order to receive CME credit for participation in these modules the learner is required to complete a post-test and achieve a score of 70% or higher for each module

Technology Requirements

Unless otherwise noted in the course materials, the following are required to access online courses: A computer or mobile device with a stable internet connection and the ability to view and update Microsoft Word® and PowerPoint® documents.  

Supported Internet Browsers


  • Internet Explorer version 11 and above
  • Chrome 43 and above
  • Firefox 4.0 (or later)


  • Safari 13 and above
  • Chrome 43 and above
Minimum Memory 8 GB (or more)
Minimum Storage 6 GB (or more)
Minimum Processor PC: 2 GHz or faster Intel processor
MacOS: Multi-core Intel processor
Minimum Internet Speeds High speed internet connection
Other Participants must be able to play audio (either through speakers or headphones) as well as ability to open PDF files and view and edit Word, and PPT documents.

Successful completion requires the learner to complete all practice-based activity components including the audiovisual presentations, post-test, and activity evaluation. Participants must receive a score of at least 70% on the post-test in order to receive credit. The post-test may be taken up to three (3) times. Learners must complete the activity evaluation in order to receive CE credit.  A link to the activity evaluation will be available once a learner has successfully completed all other course segments.

Conflict of Interest Disclosure:

In accordance with the University of Maryland School of Pharmacy Policy on Conflicts of Interest, faculty certify that they had no potential conflicts of interest while developing the materials for this program.

Privacy and Confidentiality:
The University of Maryland School of Pharmacy is committed to protecting the privacy of our learners. All enrollees are protected under The Family Educational Rights and Privacy Act (20 U.S.C. § 1232g; 34 CFR Part 99) (FERPA). The UMB Policy on Confidentiality and Disclosure of Student Records can be found at:   

In order to submit your continuing education credit to a professional accrediting body, we must collect personal information including, but not limited to, name, NABP ID, and date of birth. When you request continuing education credits, certain personal information will be provided to the professional certifying entity in order to issue Certificates of Credit.   

Copyright:  Resources are provided for the educational benefit of our learners and are not for distribution. All information and materials provided are the property of and have been prepared by the University of Maryland Baltimore or have been granted permission for use by the copyright owner.  No portion of this module may be reproduced or transmitted without written permission.  All rights reserved.

Refund Policy
  • A refund, less a $100 administration fee (for each course), will be made if cancellations are requested within 15 days of purchase. Other restrictions may apply.
  • Refund requests must be submitted in writing to
  • Refunds are not available in the following circumstances:
    • A learner has logged into a course or series;
    • Has launched course materials;
    • Course materials have been shipped; or
    • Request is made after 15 days of the ordering date.
  • Course registrations are non-transferrable.

Questions?  Review the Frequently Asked Questions page.  Can't find what you are looking for?  Contact Customer Service at or 410-706-3381.